Public trial registry of the CCC-Munich

Trial ABRAZO (Biomarin 673-201)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
ABRAZO (Biomarin 673-201)
World
Full title
:

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673) Administered to Germline BRCA Mutation Subjects with Locally Advanced and/or Metastatic Breast Cancer

World
EudraCT number
:
World
Responsible organization
:
Frauenklinik IN, Telefon: 089440054111 Lmu
Indications
Classification Code Description
ICD-10-GM C50.- Bösartige Neubildung der Brustdrüse [Mamma]
- Breastcancer
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.